Background
==========

Health-promoting microbes, defined as probiotics \[[@B1]\], have gained increased interest for use in food and dietary supplement applications to improve health and well being. Clinical research has shown that bifidobacteria are an important genus for probiotic interventions through clinical studies \[[@B2],[@B3]\]. Benefits reported using bifidobacteria include improvement of bowel functions \[[@B4]\], prevention of necrotizing enterocolitis in infants \[[@B5]\], treatment of Crohn's disease \[[@B6]\] and modulation of immune functions in the elderly \[[@B7]\]. Understanding the mechanisms of action underlying the probiotic attribute of bifidobacteria on the molecular level has been restricted to functional extrapolation from genome sequencing \[[@B8]\]. Interestingly, from the 53 *Bifidobacterium* genomes that have been deposited publicly to date, comparative analysis has revealed the genetic diversity of bifidobacteria \[[@B9]\], leading to identification of genetic loci for colon adaptation by host mucin degradation in *B. bifidum*\[[@B10]\], foraging of dietary carbohydrates in e.g. *B. longum*\[[@B11]\] or the important feature of human milk utilization \[[@B12]\] enabling colonization of the infant GIT \[[@B11],[@B13],[@B14]\] .

Enhancement of beneficial microbes within the gastrointestinal tract (GIT) can be achieved by providing selectively utilizable carbohydrates \[[@B15]\], defined as prebiotics \[[@B16]\]. Prebiotics are dietary carbohydrates, resistant to the host digestive system and main commensal microbiota residing in the colon. To date, only a few carbohydrates have been documented as prebiotics, namely β-galactooligosaccharides (GOS), lactulose, fructo-oligosaccharides and inulin \[[@B17]\]. Several candidate prebiotics have been proposed, but there is a need for additional studies that document their selective utilization by beneficial microbes within the human GIT \[[@B18],[@B19]\]. The diversity of prebiotics with respect to size, composition and glycosidic linkages require a multitude of transporters and hydrolytic enzymes, some of which are predicted to occur widely within bifidobacteria, based mostly on *in silico* analysis \[[@B20],[@B21]\].

*Bifidobacterium animalis* subsp. *lactis* has been reported to exert positive effects as a probiotic microbe in clinical studies \[[@B22],[@B23]\], or when supplemented as a synbiotic in combination with prebiotics \[[@B24]\]. The annotated genome sequence of *B. lactis* Bl-04 revealed putative prebiotic transport and catabolic pathways, suggesting the bacterium to be highly adapted to the GIT and capable of utilization of dietary-derived complex oligosaccharides \[[@B25]\]. In the present study, we used differential transcriptomics to identify genetic loci encoding uptake and hydrolytic pathways of potential prebiotics manifested by 11 structurally diverse galactosides, glucosides and xylosides within *B. lactis* Bl-04. This work validated and expanded the tentative *in silico* predictions of oligosaccharide transporters and specificities of glycoside hydrolases.

Furthermore the perspective of the study enables the combination of transcriptomics and genome mining to serve as a platform for future functional work within prebiotic utilization by bifidobacteria.

Results
=======

Oligosaccharide induced global transcriptome profile of *B. lactis* BL-04
-------------------------------------------------------------------------

Global gene expression profiles were obtained for *B. lactis* Bl-04, exponentially growing on 11 potential prebiotic oligosaccharides and glucose (Table [1](#T1){ref-type="table"}), representing α-galactosides (melibiose, raffinose and stachyose), β-galactosides (GOS), α-glucosides (isomaltose, maltotriose and panose), β-glucosides (cellobiose and gentiobiose) and β-xylosides (xylobiose and xylo-oligosaccharides (XOS)). Growth of *B. lactis* Bl-04 on various mono, di and oligosaccharides were previously published \[[@B26]\]. The gene expression levels were quantified by whole genome DNA microarrays showing an overall comparable gene expression profiles across all 12 carbohydrate treatments and with high technical reproducibility (Figure [1](#F1){ref-type="fig"}). Only a subset of genes were upregulated differentially in response to each oligosaccharide, although a slight deviation of the GOS and xylobiose samples was observed. The 10 % of the highest constitutively expressed genes for all carbohydrate treatments (163 genes) were assigned Clusters of Orthologous Groups (COG) categories \[[@B27]\] and emphasized main cellular functions of growth and energy turn-over (Figure [1](#F1){ref-type="fig"}). Notably, of the highly expressed single genes (listed by *B. lactis* Bl-04 locus tag numbers), several highlight molecular functions related to probiotic mechanisms in *B. lactis* putatively involved in fibronectin adhesion (Balac_1484--1485), host plasminogen interactions (Balac_1017 and Balac_1557), phage immunity \[[@B28]\] (Balac_1305), bile salt hydrolysis (Balac_0863) and peroxide reduction (Balac_0865). In addition, part of an oligosaccharide ATP-binding cassette (ABC) transporter encoding a solute-binding protein (SBP) (Balac_1565), and an ATP-binding protein associated with oligosaccharide uptake by ABC transporters (Balac_1610) were both found, linking catabolic adaptation to the primary physiological functions of *B. lactis* Bl-04. These findings correlate with previously proposed molecular functions related to probiotic mechanisms in *B. lactis*\[[@B29]\].

###### 

Carbohydrates, used for DNA microarray studies, listed with glycoside structure and type, supplier and purity

  **Carbohydrate**   **Structure**^**1**^                                                                                                 **Glycoside type**   **DP**^**2**^   **Manufacturer or supplier**                         **Purity (as given by Manufacturer or supplier)**
  ------------------ -------------------------------------------------------------------------------------------------------------------- -------------------- --------------- ---------------------------------------------------- ---------------------------------------------------
  Glucose            Glc*p*                                                                                                               glucoside            1               Sigma                                                \> 99%
  GOS                \[β-[d]{.smallcaps}-Gal*p*-\[[@B1]\]--\[[@B4]\]\]~n~-[d]{.smallcaps}-Glc*p*                                          galactoside          2--6            Dupont                                               \> 94% DP ≥ 2
  Melibiose          α-[d]{.smallcaps}-Gal*p*-\[[@B1]\]--\[[@B6]\]-[d]{.smallcaps}-Glc*p*                                                 galactoside          2               Sigma                                                \> 98%
  Raffinose          α-[d]{.smallcaps}-Gal*p*-\[[@B1]\]--\[[@B6]\]-[d]{.smallcaps}-Glc*p*-(α1,β2)-D-Fru*f*                                galactoside          3               Sigma                                                \> 99%
  Stachyose          \[α-[d]{.smallcaps}-Gal*p*-\[[@B1]\]--\[[@B6]\]\]~2~-[d]{.smallcaps}-Glc*p*-(α1,β2)-[d]{.smallcaps}-Fru*f*           galactoside          4               Sigma                                                \> 98%
  Isomaltose         α-[d]{.smallcaps}-Glc*p*-\[[@B1]\]--\[[@B6]\]-[d]{.smallcaps}-Glc*p*                                                 glucoside            2               Sigma                                                \> 98%
  Panose             α-[d]{.smallcaps}-Glc*p*\[[@B1]\]--\[[@B6]\]-α-[d]{.smallcaps}-Glc*p-*\[[@B1]\]--\[[@B4]\]-[d]{.smallcaps}-Glc*p*    glucoside            3               Sigma                                                \> 98%
  Maltotriose        α-[d]{.smallcaps}-Glc*p-*\[[@B1]\]--\[[@B4]\]-α-[d]{.smallcaps}-Glc*p-*\[[@B1]\]--\[[@B4]\]-[d]{.smallcaps}-Glc*p*   glucoside            3               Dupont                                               \> 95%
  Cellobiose         β-[d]{.smallcaps}-Glc*p*-\[[@B1]\]--\[[@B4]\]-[d]{.smallcaps}-Glc*p*                                                 glucoside            2               Fluka AG                                             \> 99%
  Gentiobiose        β-[d]{.smallcaps}-Glc*p*-\[[@B1]\]--\[[@B6]\]-[d-]{.smallcaps}Glc*p*                                                 glucoside            2               Sigma                                                \> 98%
  Xylobiose          β-[d]{.smallcaps}-xyl*p*-\[[@B1]\]--\[[@B4]\]-[d]{.smallcaps}-xyl*p*                                                 xyloside             2               Dupont                                               \> 95%
  XOS                \[β-[d-]{.smallcaps}xyl*p*-\[[@B1]\]--\[[@B4]\]\]~m~-[d]{.smallcaps}-xyl*p*                                          xyloside             2--7            Shandong Longlive Bio-technology Co., Ltd, (China)   \> 90%^3^

^1^n = 1--5 as previously described \[[@B70]\], m =1--6 as stated by manufacturer.

^2^Degree of polymerization.

^3^The XOS composition and purity was previously determined \[[@B60]\].

![**Two-way clustering of the global gene expression profiles and COG distribution of constitutively expressed genes.** Gene expression intensities are represented by red coloring: up-regulation, blue coloring: down-regulation. Technical replicates for each carbohydrate are numbered and showed overall high reproducibility. The highest expressed decile (163 genes) of the global transcriptome across all carbohydrates conditions was assigned COG categories (assigned both as numbers and percentages), highlighting essential metabolic pathways of *B. lactis* Bl-04.](1471-2164-14-312-1){#F1}

Functional grouping of global gene expression was observed based on the type of glycoside utilized (galactosides, glucosides or xylosides) from principal component analysis (Figure [2](#F2){ref-type="fig"}). A clear differentiation of the expressed global transcriptome was observed based on the type of glycoside utilized, indicating that prebiotics can affect the global transcriptome, and therefore physiological functions in *B. lactis* Bl-04. Furthermore, specific genetic loci were significantly differentially regulated by specific carbohydrates, which indicates their potential involvement in the uptake and catabolism of the respective glycosides (Figure [1](#F1){ref-type="fig"}).

![**Principal component analysis of the global transcriptome for*B. lactis*Bl-04 cultivated with prebiotics showing differentiation of the global gene expression profiles depending on the glycoside type of carbohydrates utilized (pca2 = 22.2%).** Galactosides in red (GOS, melibiose, raffinose, stachyose), glucosides in green (cellobiose, gentiobiose, glucose, maltotriose, isomaltose, panose) and xylosides in blue (XOS, xylobiose).](1471-2164-14-312-2){#F2}

Differentially upregulated genes conferring potential prebiotic utilization
---------------------------------------------------------------------------

Analysis of the differential upregulation of specific genes mediating potential prebiotic utilization was conducted by one-way analysis of variance (ANOVA) and visualized by volcano plots (Figure [3](#F3){ref-type="fig"}) to identify statistically significant genes (cut off: p-value \< 10^-8.04^) upregulated by each carbohydrate in the whole genome DNA microarray. An average of 56 genes were more than 2-fold differentially upregulated and above the statistical threshold for each pairwise comparison. Analysis revealed how subsets of genes involved with oligosaccharide metabolism were consistently differentially expressed throughout the ANOVA (Table [2](#T2){ref-type="table"}, and Figure [4](#F4){ref-type="fig"} for real time quantitative-PCR validation of selected genes). This led to the reconstruction of six putative gene clusters based on the differential upregulation of specific genes to specific oligosaccharide treatments. Gene clusters encoding a transporter and glycoside hydrolase(s) were linked to the uptake and degradation of substrates that varied in the degree of polymerization, glycosidic linkage or monosaccharide composition.

![**Representative volcano plots of pairwise comparisons of the oligosaccharide-induced differential global transcriptome in*B. lactis*Bl-04.** All genes are shown by solid grey circles, and putative carbohydrate-active protein encoding genes that were significantly up-regulated are highlighted with solid circles and color-coded by gene cluster and as listed in Table [2](#T2){ref-type="table"}: cluster **A** (blue), cluster **B** (orange), cluster **C** (purple), cluster **D** (light blue), cluster **E** (green) and cluster **F** (red).](1471-2164-14-312-3){#F3}

###### 

Statistically significant upregulated genes involved in carbohydrate uptake and catabolism

  **ORF**                     **Gene annotation**                  **Inducing CHO type**    **Volcano plot (Figure**[3](#F3){ref-type="fig"}**)**   **Highest inducing CHO**   **Gene cluster (Figure**[5](#F5){ref-type="fig"}**)**   **Fold upregulated**   **-log**~**10**~**(P-value)**
  ------------ -------------------------------------------------- ------------------------ ------------------------------------------------------- -------------------------- ------------------------------------------------------- ---------------------- -------------------------------
  Balac_0053                 β-galactosidase, GH42                       Glucoside                                    C                                   gentiobiose                                    A                                     6.5                        13.8
  Balac_0054                      MFS permease                           Glucoside                                    C                                   gentiobiose                                    A                                     4.8                        11.8
  Balac_0475                      MFS permease                          Galactoside                                   A                                       GOS                                        B                                     21.8                       19.9
  Balac_0476                  β-galactosidase, GH2                      Galactoside                                   A                                       GOS                                        B                                     36.9                       17.9
  Balac_0484                 β-galactosidase, GH42                      Galactoside                                   A                                       GOS                                        C                                     11.4                       17.2
  Balac_0485          ABC transporter, permease component               Galactoside                                   A                                       GOS                                        C                                     8.4                        16.2
  Balac_0486          ABC transporter, permease component               Galactoside                                   A                                       GOS                                        C                                     5.7                        12.9
  Balac_0511                    Xylose isomerase                          xyloside                                   A,C                                      XOS                                        D                                     13.8                       15.1
  Balac_0512      α-[l]{.smallcaps}-arabinofuranosidase, GH43             xyloside                                   A,C                                      XOS                                        D                                     6.8                        13.6
  Balac_0513        Transcriptional regulator (*lacI* type)               xyloside                                   A,C                                   Xylobiose                                     D                                     3.0                        10.1
  Balac_0514    ABC transporter, oligosaccharide-binding protein          xyloside                                   A,C                                      XOS                                        D                                     9.0                        16.0
  Balac_0515          ABC transporter, permease component                 xyloside                                   A,C                                      XOS                                        D                                     16.8                       16.5
  Balac_0516          ABC transporter, permease component                 xyloside                                   A,C                                      XOS                                        D                                     18.3                       17.5
  Balac_0517                   β-xylosidase, GH43                         xyloside                                   A,C                                      XOS                                        D                                     17.9                       16.1
  Balac_0518             Putative carbohydrate esterase                   xyloside                                   A,C                                      XOS                                        D                                     14.2                       11.3
  Balac_0519                        Esterase                              xyloside                                   A,C                                      XOS                                        D                                     6.9                        15.1
  Balac_0520      α-[l]{.smallcaps}-arabinofuranosidase, GH43             xyloside                                   A,C                                      XOS                                        D                                     10.2                       15.2
  Balac_0521                    Xylulose kinase                           xyloside                                   A,C                                   Xylobiose                                     D                                     18.2                       19.0
  Balac_1567                 4-α-glucanotransferase                      glucoside                                   B,D                                   Maltriose                                     E                                     9.7                        14.5
  Balac_1569          ABC transporter, permease component                glucoside                                   B,D                                   Cellobiose                                    E                                     5.2                        13.7
  Balac_1570          ABC transporter, permease component                glucoside                                   B,D                                   Cellobiose                                    E                                     3.7                        15.1
  Balac_1571        Transcriptional regulator (*lacI* type)              glucoside                                   B,D                                   Cellobiose                                    E                                     3.7                        13.1
  Balac_1572    ABC transporter, oligosaccharide-binding protein         glucoside                                   B,D                                   Cellobiose                                    E                                     3.2                        12.1
  Balac_1593             oligo-1,6-α-glucosidase, GH13             Galactoside, Glucoside                           B,D,E                                  Isomaltose                                    F                                     4.5                        14.0
  Balac_1597          ABC transporter, permease component          Galactoside, Glucoside                           B,D,E                                  Raffinose                                     F                                     14.1                       13.9
  Balac_1598          ABC transporter, permease component          Galactoside, Glucoside                           B,D,E                                  Isomaltose                                    F                                     20.1                       18.6
  Balac_1599    ABC transporter, oligosaccharide-binding protein   Galactoside, Glucoside                           B,D,E                                  Isomaltose                                    F                                     17.8                       16.7
  Balac_1601                 α-galactosidase, GH36                 Galactoside, Glucoside                           B,D,E                                  Raffinose                                     F                                     8.1                        16.4

The genes are listed by ascending locus tag numbers with the principle type of glycoside. Only the oligosaccharide that elicited the highest significance level (−log~10~(P-value)) is listed for genes that are upregulated by more than one oligosaccharide.

![**Heat map representation of RT-qPCR validation of microarray gene expression values.** The mRNA transcript level were quantified for each of the five genes in each of the 12 carbohydrate conditions and color-coded as the relative fold upregulation of each gene: Blue \[1--2\], light blue \[5--9\], red \[9--17\] and strong red \[\>16\].](1471-2164-14-312-4){#F4}

Moreover, the relative induction of gene clusters involved in carbohydrate uptake and catabolism (Figure [5](#F5){ref-type="fig"}) strongly supports the identification of the differential specificities of upregulated proteins involved with utilization of the various oligosaccharides.

![**Two-way clustering of the expression profile for genes identified to be differentially upregulated by ANOVA.** The coloring of each ORF corresponds to the gene cluster of Figure [2](#F2){ref-type="fig"} and Table [2](#T2){ref-type="table"}.](1471-2164-14-312-5){#F5}

Gene cluster analysis and functional assignment
-----------------------------------------------

Analysis of differentially up-regulated loci enabled the identification of six gene clusters conferring the uptake and hydrolysis of the oligosaccharides used in the study (Figure [6](#F6){ref-type="fig"}A--F). Common to all the identified loci is that they encoded a transport system, a transcriptional regulator and one or more glycoside hydrolases (GHs) as predicted from the glycoside hydrolase family annotation in the CAZy database \[[@B30]\] (Figure [3](#F3){ref-type="fig"}). Four ATP-binding cassette (ABC) systems and two major facilitator superfamily (MFS) transporters, including one putative glycoside-pentoside-hexuronide (GPH) system were identified \[[@B31]\], supporting the differential expression of gene clusters being induced by multiple oligosaccharides (Figure [3](#F3){ref-type="fig"}).

![**Organization of differentially expressed gene clusters encoding proteins predicted to be involved with prebiotic utilization.** Genes are listed with locus tag numbers and gene functions are colored as: glycoside hydrolases in red, ABC transporter SBPs- and permeases (perm) in green, MFS transporters in blue, transcriptional regulators (reg) in light grey and hypothetical proteins (hypo), carbohydrate esterases (ester1 and ester2), xylose isomerase (xyl.iso) and xylulose kinase (xyl.kin) all in dark gray. A short putative nonfunctional ORF is highlighted by a black triangle.](1471-2164-14-312-6){#F6}

Gene cluster A, differentially up-regulated by gentiobiose, encoded an MFS transporter (Balac_0054), with only 25% amino acid sequence identity to a sucrose permease from *Arabidopsis thaliana* (uniprot: Q9FG00), and an intracellular (as predicted by SignalP 4.0 \[[@B32]\]) putative β-galactosidase of GH42 (Balac_0053), adjacent to a GH30 subfamily 1 (GH30_1) putative β-glucosidase (Balac_0052) \[[@B33]\] not identified from the ANOVA. Interestingly, GH42 enzymes are only reported to be active on β-galactoside linkages \[[@B34]\], whereas GH30_1 enzymes harbor several specificities including endo-β-\[[@B1],[@B4]\]-glucosidases rendering the GH30_1 a likely candidate for gentiobiose hydrolysis. Interestingly, co-occurrence of the GH42 and the GH30_1 genes is also observed in other bifidobacteria e.g. *B. adolescentis* ATCC 15703 and *B. dentium* Bd1. The rationale for the co-occurrence of these two GH genes is currently unclear, but the data identifies a novel route for gentiobiose uptake via the MFS transporter and hydrolysis by the putative GH30_1 family β-\[[@B1],[@B4]\]-glucosidase.

The GOS substrate upregulated the expression of two loci: an MFS transporter (Balac_0475) homologous to the lactose transporter from *B. longum* NCC2705 \[[@B35]\], and a typical GH2 β-galactosidase (Balac_0476, cluster B) and cluster C (Balac_0483--0486) encoding the heterodimeric permease and the solute binding protein of an ABC transport system along with a GH42 putative β-galactosidase. The upregulation of two loci with a similar architecture was also reported in *B. breve*\[[@B36]\].

Xylobiose and XOS induced locus D encoding an ABC transporter, a putative GH43 β-xylosidase (Balac_0517) and two putative GH43 arabinofuranosidases (Balac_0512 and Balac_0520) identified based on homology to characterized bifidobacterial enzymes \[[@B37],[@B38]\]. This suggests that the gene cluster mediates the transport and hydrolysis of both undecorated and arabinosyl-decorated XOS. The gene cluster also encodes a xylose isomerase and a xylulose kinase necessary to convert xylose to 2-xylulose-5 phosphate for entry into the bifid-shunt pathway \[[@B39]\]. The removal of acetyl sidechains that typically occur at the C2 or C3 of mainchain xyloxyl residues and feruloyl esters at the C5 or C2 of arabinosyl decorations in arabinoxylan is a prerequisite for the utilization of decorated arabinoxylo-oligosaccharides \[[@B40]\]. Notably, two putative carbohydrate esterases (Balac_0518 and Balac_0519) were upregulated highlighting the ability of the *B. animlais* subsp. *lactis* to remove acetyl or feruloyl sidechains from imported arabinoxylan fragments.

The organization and type of genes in cluster E showed resemblance to maltose operons from *B. longum* NCC2705 \[[@B35]\]. In the current study, however, the gene cluster was also upregulated by the trisaccharides panose, maltotriose and remarkably the β-linked disaccharide cellobiose. The gene landscape of this maltooligosaccharide gene cluster differed in the types of glycoside hydrolases encoded in the comparison to counterparts reported in other Gram positive bacteria \[[@B41]\]--\[[@B43]\] suggesting divergence in α-glucan metabolism.

An ABC transporter was identified in cluster F and was induced by the raffinose family oligosaccharides (RFO) melibiose, raffinose and stachyose representing α-1,6 linked galactosides, along with the α-1,6 linked glucosides isomaltose and panose. The GH36 subfamily 1 (GH36_1, Balac_1601) α-galactosidase \[[@B44]\] confers the hydrolysis of the α-1,6 linked galactosides, while the GH13 oligo-α-1,6-glucosidase (Balac_1593) catalyzes the hydrolysis of α-1,6 linked glucosides \[[@B45]\]. *B. lactis* Bl-04 encoded a total of three GH36, yet the remaining two (Balac_1537 and Balac_1596) were not differentially expressed. Further analysis of the global transcriptome (Figure [1](#F1){ref-type="fig"}) showed low basal expression of Balac_1537 in all conditions suggesting that the gene product plays a continuous metabolic role in cell function, while Balac_1596, assigned to GH36_2 (homologous to plant raffinose synthases \[[@B44]\]) was not expressed under these conditions.

In summary, all proposed pathways deduced from the identified gene clusters are shown in Figure [7](#F7){ref-type="fig"}, where potential prebiotic oligosaccharides are internalized and hydrolyzed into products that can be metabolized by the bifid shunt pathway \[[@B39]\]. Consistently, the majority of the bifid shunt genes were found to be highly expressed in all conditions as marked in Figure [7](#F7){ref-type="fig"}. Notably, a single putative phosphoketolase gene is encoded in *B. lactis* Bl-04, suggesting that this gene product could phosphorolyse both fructose-6P and xylulose-5P as the initial step of the bifid shunt, as previously described within *B. lactis*\[[@B46]\].

![**Proposed pathways for oligosaccharide uptake and catabolism into monosaccharides for entry into the bifid shunt.** Transporters are colored as in Figure [6](#F6){ref-type="fig"} and all genes are given by their locus tag. The schematic pathways for glucose (entering as glucose-1P), galactose, fructose (entering as fructose-6P) and xylose are shown with the main steps of the bifid shunt. All constitutive highly expressed genes (Figure [1](#F1){ref-type="fig"}) are denoted with an asterisk (**\***)](1471-2164-14-312-7){#F7}

Differentiation of transporter functionalities by transmembrane topology and sequence diversity
-----------------------------------------------------------------------------------------------

To differentiate the functionality of ABC and MFS transporters, the putative α-helical topology of the membrane spanning domains of all predicted oligosaccharide transporters in *B. lactis* Bl-04 was mapped (Table [3](#T3){ref-type="table"}). Notably, the gentiobiose-specific MFS transporter (Balac_0054) possesses 11 predicted transmembrane helices, indicating structural-functional divergence from previously identified homologous MFS permeases displaying mainly 12 transmembrane helix topology \[[@B47]\]. Furthermore, one permease protein (Balac_1570) constituting part of the maltotriose upregulated ABC transporter was found to be N-terminally truncated and lacking two helices implicated in heterodimer formation in the permease domain of the maltose ABC transporter from *Escherichia coli*\[[@B48]\]. Comparison to an additional putative *B. lactis* Bl-04 maltose transporter (Balac_1563--1565) and the experimentally verified maltose ABC transporters from *Lactobacillus casei*\[[@B42]\] and *Streptococcus pneumoniae*\[[@B49]\] showed that all harbored the additional two α-helical domain, suggesting the divergence of the maltotriose ABC transporter (Balac_1569, 1570 and 1572) from known maltose ABC transporters.

###### 

**Prediction of α-helical topology within oligosaccharide transporters identified in*B. lactis*Bl-04**

  **ORF**   **Predicted substrates**        **Class**            **Predicted TMH**^**1**^   **Sequence length (aa)**
  --------- ------------------------------- -------------------- -------------------------- --------------------------
  0054      Gentiobiose                     MFS                  11                         384
  0139      Sucrose (putative)              MFS                  12                         537
  0475      GOS                             GPH homolog of MFS   12                         505
  1240      FOS (putative)                  MFS                  12                         441
  1588      arabinofuranosides (putative)   GPH homolog of MFS   12                         481
  0485      GOS                             ABC                  6                          326
  0486      GOS                             ABC                  6                          322
  0515      XOS                             ABC                  6                          352
  0516      XOS                             ABC                  6                          289
  1563      Maltose (putative)              ABC                  6                          322
  1564      Maltose (putative)              ABC                  8                          457
  1569      Maltotriose                     ABC                  6                          278
  1570      Maltotriose                     ABC                  6                          284
  1597      RFO + IMO                       ABC                  6                          301
  1598      RFO + IMO                       ABC                  6                          330

^1^Transmembrane α-helices (TMH) predicted using the Phobius tool \[[@B71]\].

Four of the five *in silico* annotated ABC transporters \[[@B25]\] were found to be differentially upregulated, while the remaining putative maltose ABC transporter discussed above (Balac_1563--1565) was found to be constitutively expressed to a comparable level. The transcriptomics data enabled the identification of novel specificities and multiple ligand recognition by the SBPs, recognized as specificity determinants for ABC transporters \[[@B50]\]. This is in agreement with the binding plasticity proposed for ABC-mediated transport \[[@B50]\]. To elaborate on these findings, the phylogenetics of the SBPs were compared to known protein orthologs (Supplemental Table) identified from bifidobacteria and pathogenic GIT-associated bacteria (Figure [8](#F8){ref-type="fig"}), hence displaying the functional and taxonomical distribution of oligosaccharide SBPs.

![**Functional comparison of the identified oligosaccharide SBPs of ABC transporters in*B. lactis*Bl-04.** The phylogenetic tree was rooted by a characterized fructose-binding protein \[[@B69]\] as a functional and structural outlier group of oligosaccharide-binding proteins \[[@B50]\]. Sub-clusters were defined by bootstrap values in percentages and the characterized SBP(s) identified within each sub-cluster, where the number of sequences are listed in brackets. The tree was colored by substrate specificity (maltose-binding proteins (green), cellodextrins (orange), GOS and lacto-*N*-biose (blue), XOS (light blue) and raffinose family oligosaccharides (red)) and sub-clusters were denoted by numbers as given in Table [4](#T4){ref-type="table"}. The raffinose family oligosaccharide cluster was seemingly sub-clustering into two parts but with the current data could not be supported by boot-strap analysis.](1471-2164-14-312-8){#F8}

Discussion
==========

Bifidobacteria have been shown to exert a positive influence on the human gut \[[@B51]\] and may selectively utilize oligosaccharides of plant and milk-derived prebiotics \[[@B52]\]. Despite significant advances in bacterial genomics, understanding of carbohydrate uptake and catabolism mechanisms remains elusive, mainly because of poor overall annotation of oligosaccharide transporters where recent advances in uptake of human derived glycans \[[@B53]\] combined with the present study will enable improved functional overview of the *Bifidobacterium* genus with respect to carbohydrate utilization as an important factor for competitive GIT colonization and pathogen inhibition.

The global transcriptome of *B. lactis* Bl-04
---------------------------------------------

The catabolic adaptation potential of *B. lactis* Bl-04 became apparent from the global comparison of oligosaccharide induced gene expression by principal component analysis (Figure [2](#F2){ref-type="fig"}). The altered global gene expression by the type of glycoside metabolized (galactoside, glucoside or xyloside) was not influenced by the differentially expressed gene clusters involved in the uptake and catabolism of oligosaccharides. It is likely that global gene expression, induced by carbohydrate source, involves modulation of the metabolic equilibrium within the bacterium. This was observed in *B. longum* for glycoside-induced changes in exopolysaccharide production \[[@B54]\] and the inhibition of enteropathogens by acidification when metabolizing fructose rather than glucose \[[@B55]\]. These findings underscore the effects associated with the catabolism of glycoside type on the overall behavior and potentially probiotic functionality of bifidobacteria in the GIT. Because of the importance for selective utilization of oligosaccharides, we hypothesize a vital role of ABC transporters for prebiotic uptake. Interestingly, a sole oligosaccharide ABC transporter-specific ATP-binding protein was identified in the genome and found to be constitutively highly expressed, consistent with a single ATP-binding protein energizing multiple oligosaccharide ABC transporters as previously described \[[@B56]\]. Likewise, various genes encoding proteins linked to proposed probiotic mechanisms of action, such as adhesion (Balac_1484--1485), phage immunity (Balac_1305) and bile salt hydrolysis (Balac_0863) were found to be highly expressed, supporting the clinically proven probiotic nature of *B. lactis* Bl-04 and reflecting the adaptation to the conditions of the GIT.

Analysis of the differentially expressed genes of *B. lactis* Bl-04 involved in prebiotic utilization revealed upregulation of explicit gene clusters, as was also observed from previous studies of oligosaccharide utilization in probiotic bacteria \[[@B35],[@B57]\]. The uptake of oligosaccharides was facilitated by ABC and MFS types of oligosaccharide transporters, by the lack of phosphoenolpyruvate-dependent phosphotransferase systems in the *B. lactis* Bl-04 genome \[[@B25]\], all associated with glycoside hydrolases.

Oligosaccharide ABC transporters
--------------------------------

The phylogenetic analysis of homologs of identified ABC transporters allowed the assignment of the SBPs identified in the current study into functional clusters harboring experimentally identified counterparts. Within each functional cluster, protein orthologs segregated based on taxonomic distance. Evolutionary adaptation was evident from this analysis as the milk disaccharide lacto-*N*-biose specificity defined by cluster LacN is almost exclusively found within bifidobacteria, while XOS SBP orthologs were dominated by soil bacteria and few GIT associated bacteria with the majority originating from Actinobacteria. This suggests that XOS utilization by bifidobacteria shares a metabolic niche within the GIT with xylan utilizing commensal bacteria \[[@B58]\].

The phylogenetic analysis indicates convergent evolution of a subset of maltose ABC transporter, based on the upregulated maltotriose ABC transporter (Balac_1569, 1570 and 1572). The diversity of canonical maltose SBP orthologs was illustrated by their segregation into four sub-clusters (clusters Mal1--Mal4), where a taxonomical sub-clustering was observed. A distant sub-cluster (Mal5) was defined by the maltotriose upregulated binding protein (Balac_1572). Notably, the corresponding permease domain of this ABC transporter was distinguished from identified maltose specific counterparts by the lack of two N-terminal α-helices (Balac_1570, Table [3](#T3){ref-type="table"}), supporting the proposed convergent nature of this type of maltose transporter, which seems to share topological features with the raffinose and XOS type binding proteins (Figure [8](#F8){ref-type="fig"}).

Novel specificities of glycoside hydrolases for GIT adaptation
--------------------------------------------------------------

Identification of single gene being differentially upregulated by specific oligosaccharides revealed novel enzyme substrate specificities as compared to the initial *in silico* annotation of the hydrolytic capabilities of *B. lactic* Bl-04 \[[@B25]\]. Interestingly, the observation of a GH42 β-galactosidase being induced by the β-1,6-glucoside gentiobiose was intriguing as only β-galactosidases have been reported in this family. Thus, the GH30_1 putative β-glucosidase is the more likely candidate for gentiobiose hydrolysis. Nonetheless, the transcriptomics data suggests that gentiobiose is specifically transported by the MFS permease, thus defining a novel specificity for this MFS transporter. It remains to be investigated if additional substrates are taken up by the MFS permease including possible substrates for the upregulated GH42, which exhibits modest sequence identity (≈30%) to characterized GH42 enzymes.

No putative glycoside hydrolase was differentially up-regulated on cellobiose. However, transcriptional mining of *B. lactis* Bl-04 identified a constitutively expressed GH1 β-glucosidase (Balac_0151). The β-glucosidase displayed 51% amino acid identity to the GH1 β-glucosidase from *B. brevis* UCC2003 shown to be active on cellobiose and cellodextrin (β-1,4-glucooligosaccharides) initially transported by an ABC transporter \[[@B59]\], supporting the suggested function of Balac_0151. Furthermore, the only transporter differentially up-regulated on cellobiose was the above ABC transporter (Balac_1572) which was also up-regulated by maltotriose (Figure [5](#F5){ref-type="fig"}). This indicates a potentially dual specificity of the transporter likely to have evolved from multiple sugar metabolism-types of oligosaccharide ABC transporters (Figure [8](#F8){ref-type="fig"}).

The uptake and catabolism of XOS within bifidobacteria was recently proposed \[[@B37],[@B60]\]. Comparative genomic of genes involved with XOS utilization within bifidobacteria (Figure [9](#F9){ref-type="fig"}) reflected a core gene structure of the XOS ABC transporter with a GH43 β-1,4-xylosidase (Balac_0517), while the occurrence of arabino-furanosidases, xylanases of GH8 and GH120 and carbohydrate esterases suggested more species and strain specific adaptation to utilize specific types of XOS *e.g.* arabinosyl decorated fragments. The multiplicity of GH43 arabino-furanosidases reflects the complexity of arabinosyl decorations that occurs naturally in arabinoxylan and its degradation products. Two putative oligosaccharide esterases, distantly related to previously identified xylan acetyl esterases \[[@B61]\] and conserved among bifidobacteria, were upregulated by XOS and xylobiose in *B. lactis* Bl-04. This implicates these putative esterases in de-esterification of xylan fragments transported into bifidobacteria. Taken together, this suggests an exquisite metabolic versatility in the uptake and utilization of xlyan degradation fragments that occur naturally with a diversity of arabinosyl and esterified side chain decorations.

![**Genomic content and organization of XOS utilization gene clusters identified within bifidobacteria.** All strains were ordered top down by highest sequence similarity of the XOS-binding proteins to the XOS-binding protein of *B. lactis* Bl-04 (balac_0514). Gene functions are colored as: Glycoside hydrolases (red), XOS ABC transporters (green), xylose ABC transporters (light green), transcriptional regulators (light grey), and putative XOS esterases, xylose isomerases (xyl.iso), xylulose kinases (xyl.kin), alcohol dehydrogenases (Reductase) and a putative secreted amidase (lysM) (all dark gray). All GH43 enzymes were annotated and differentiated by protein similarity to previously characterized xylosidases (xyln) or arabinofuranosidases (arab) together with the GH8 and GH120 enzymes \[[@B37],[@B38]\]. An insertion in *B. longum* JDM301 is shown by below the gene cluster with an arrow indicating the position of the insert.](1471-2164-14-312-9){#F9}

The ABC transporter mediated uptake of GOS coupled with co-induction of a GH42 showed homology to a *B. longum* NCC2705 gene cluster upregulated by lactose \[[@B35]\]. Interestingly this gene cluster diverges from those identified for human milk oligosaccharide uptake \[[@B62]\] both by the similarity of the associated SBP (Figure [8](#F8){ref-type="fig"}, LacN versus GOS) and the GH encoded in the gene clusters (GH42 versus GH112). Therefore, *B. lactis* Bl-04 has evolved a broad oligosaccharide utilization profile for potential prebiotics and dietary fibers.

Conclusion
==========

In conclusion, the overall global gene expression of *B. lactis* Bl-04 was dependent of the type of glycoside utilized (galactosides, glucosides or xylosides) potentially linking the prebiotic catabolism of the bacteria to the overall behavior in the GIT. From the transcriptional analyses, we identified the genetic loci encoding MFS and ABC transporters concurrently with glycoside hydrolases for utilization of potential prebiotic oligosaccharides of α- and β-linkages and varying glycoside composition. This highlights the metabolic versatility of *B. lactis* Bl-04 and offers a means of enhancing probiotic effects by dietary supplementation with novel prebiotics. Furthermore, this study provides molecular level support for utilization of potential prebiotics, some of which are already known to be bifidogenic, and paves the way for expanding synbiotic formulations targeting specific groups of probiotic bacteria.

Methods
=======

Culture preparation
-------------------

*B. animalis* subsp. *lactis* Bl-04 (ATCC SD5219) was originally isolated from a human fecal sample \[[@B25]\]. Cultures prepared for transcriptional analysis were propagated in 0.22 μm filtered LABSEM media \[[@B63]\] pretreated by the Hungate method for oxygen removal \[[@B64]\]. The media was supplemented with 1% (w/v) of the 12 tested carbohydrates (Table [1](#T1){ref-type="table"}) and each culture was transferred for five passages, under anaerobic conditions, on each carbohydrate before being harvested in the early logarithmic growth phase (*OD*~600~ = 0.3--0.5) by centrifugation at 4°C (3,000 g for 15 min) and flash freezing of the cell pellet for storage.

RNA isolation and microarray hybridization
------------------------------------------

Cells were mechanically disrupted by beadbeating and total RNA was isolated using Trizol-chloroform extraction (Invitrogen, Carlsbad, CA). Genomic DNA was removed with Turbo DNAse (Ambion, Austin, TX), followed by RNA purification using a RNeasy Mini Kit (Qiagen Inc., Valencia, CA) \[[@B65]\].

Reverse transcription of total RNA, fragmentation and 3' biotin labeling of cDNA was done using 10 μg of total RNA in duplicates for each of the 12 conditions and microarray hybridizations were performed using the Affymetrix GeneChip® system (Affymetrix, Santa Clara, CA). Total RNA was reverse transcribed using random primers and SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, California) and cDNA was purified using MinElute PCR Purification kit (QIAGEN, Inc., Valencia, CA) with a final elution volume of 12 μl. Subsequently, cDNA fragmentation into 50--100 bp was performed using DNase I (GE Healthcare, Waukesha, WI) and cDNA fragments were biotin-labeled using GeneChip DNA labeling reagent (Affymetrix) and terminal deoxynucleotidyl transferase (Promega, Madison, WI).

Labeled cDNA fragments were hybridized at Utah State University using Affymetrix custom-made chips. All extracted data was imported into SAS JMP Genomics (SAS Institute Inc, Cary, NC) before being quantile normalized and modeled using a one-way ANOVA for identification of differentially upregulated genes using a threshold value of α = 0.005 and Bonferroni correction.

The full genome transcriptome (98.1% of the total ORF) for each of the 12 growth conditions was used for the one-way ANOVA analysis. The pairwise analysis was done by comparing each single condition to the other 11 for a total of 66 pairwise conditions. To each of these 66 comparisons, the ANOVA identified a number of genes that were significantly upregulated, for further *in silico* validation by real-time quantative PCR of selected genes. The identified upregulated genes from the ANOVA were then annotated for potential involvement in carbohydrate utilization.

Real-time quantitative PCR (RT-qPCR) validation of microarray
-------------------------------------------------------------

RT-qPCR was performed on five selected genes (Table [3](#T3){ref-type="table"}) found to be differentially upregulated. The DNAse-treated total RNA, identical to the RNA used in microarray sample preparation, was used as template for each of the above 12 growth conditions, measured in triplicates. Experiments were conducted with a QRT-PCR thermal cycler (I-cycler; Bio-Rad, Hercules, CA) in combination with the iScript One-Step RT-PCR Kit with SYBR Green (Biorad).

Construction of phylogenetic tree of carbohydrate SBPs
------------------------------------------------------

The sequence dataset was compiled from oligosaccharide-binding proteins all identified from previous works or from the current study (Table [4](#T4){ref-type="table"}). Sequence homologs for each protein entry were identified by BLAST \[[@B66]\] and restricted to either 100 hits or an e-value of 10^-3^ against the non-redundant database. All redundant sequences were removed and the remaining sequences together with a monosaccharide (fructose) binding proteins were aligned with ClustalX \[[@B67]\] using the Blosum series substitution matrix and a gap opening penalty of 2, compared to the standard penalty of 10. The resulting phylogenetic tree file was visualized using Dendroscope \[[@B68]\]. Bootstrap values were calculated by ClustalX using standard conditions (1000 iterations).

###### 

**Identified clusters of oligosaccharide-binding proteins from Figure**[8](#F8){ref-type="fig"}

           **Cluster**            **Sub-cluster**   **Substrate specificity**        **Identified Organism**              **Reference**
  ----------------------------- ------------------- -------------------------------- ------------------------------------ ----------------
     Malto-oligosaccharides              1          α-(1,4)-gluco-oligosaccharides   *Listeria monocytogenes*             \[[@B72]\]
   *Streptococcus pneumoniae*       \[[@B73]\]                                                                            
                                         2          β-Cyclodextrin and maltose       *Bacillus subtilis*                  \[[@B74]\]
                                         3          Maltose                          *L. casei* BL23                      \[[@B42]\]
                                         4          Putative maltose                 *B. animalis* subsp *lactis* Bl-04   This study
                                         5          Maltose                          *B. longum* NCC2705                  \[[@B35]\]
           Maltotriose           *B. lactis* Bl-04  This study                                                            
          β-glucosides                  \-          β-(1,4)-gluco-oligosaccharides   *B. breve* UCC2003                   \[[@B59]\]
         β-galactosides                  A          Lactose and                      *B. longum* NCC2705                  \[[@B35]\] and
   β-galacto-oligosaccharides    *B. lactis* Bl-04  This study                                                            
                                         B          Lacto-*N*-biose                  *B. bifidum*                         \[[@B75]\]
                                    *B. longum*     \[[@B76]\]                                                            
               XOS                      \-          β-(1,4)-xylo-oligosaccharides    *B. lactis* Bl-04                    This study
               RFO                       A          Raffinose and isomaltose         *Streptococcus mutans*               \[[@B43]\]
                                         B          Raffinose                        *B. longum* NCC2705                  \[[@B35]\]
   Raffinose and Isomaltose^1^   *B. lactis* Bl-04  This study                                                            
              Root                      \-          Fructose                         *B. longum* NCC2705                  \[[@B69]\]

Clusters are shown by numbers and if possible sub-clusters are listed with letters. The experimentally identified oligosaccharide-binding proteins used to generate the tree are listed in the corresponding cluster and sub-cluster if possible.

^1^Including melibiose, panose and stachyose.

###### 

Primer pairs used for RT-qPCR

  **ORF**               **Primer 5\' -- 3\'**   **Product size (bp)**
  --------------------- ----------------------- -----------------------
  0054                  CACACTCGCTCGAGATTC      140
  AGGCCAATCATGCATACG                            
  0475                  GCTGACGATGGGAATGAC      160
  GCTCGACGTGTTCTACTC                            
  0483                  CGTCGGAGTTCTTGATGG      142
  CAGGCAGCCTATGACTTC                            
  0514                  GGCTGACCTTGGATTCTT      145
  CTTCTCGCCCATGTAGTTG                           
  1565                  GAACGCCGTAGATCTTGC      148
                        ATGTTCGCCAATGACCAG       

Microarray submission
---------------------

All raw data have been deposited in the GEO database (Accession number: GSE41906) and complies with the MIAME guidelines.
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